WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008098232) METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/098232    International Application No.:    PCT/US2008/053522
Publication Date: 14.08.2008 International Filing Date: 08.02.2008
IPC:
A01N 43/42 (2006.01)
Applicants: GRACEWAY PHARMACEUTICALS, LLC [--/US]; 340 Martin Luther King Jr., Blvd. Suite 500, Bristol, TN 37620 (US) (For All Designated States Except US).
GREGORY, Jefferson, J. [US/US]; (US) (For US Only)
Inventors: GREGORY, Jefferson, J.; (US)
Agent: MANSO, Peter, J.; Edwards Angell Palmer & Dodge LLP, P.O. Box 55874, Boston, MA 02205 (US)
Priority Data:
60/900,550 08.02.2007 US
Title (EN) METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPY
(FR) PROCÉDÉ DE TRAITEMENT DE TROUBLES DERMATOLOGIQUES ET D'INDUCTION DE LA BIOSYNTHÈSE DE L'INTERFÉRON AVEC DES DURÉES DE THÉRAPIE À L'IMIQUIMOD PLUS COURTES
Abstract: front page image
(EN)Pharmaceutical formulations and methods for the topical and/or transdermal delivery of imiquimod, including creams, ointments and pressure-sensitive adhesive compositions to treat dermatological disorders, namely, viral infections, such as Type I or Type II Herpes simplex infections and genital warts, actinic keratosis and superficial basal cell carcinoma, and to induce interferon biosynthesis, with shorter durations of therapy, than currently approved for imiquimod by the Food & Drug Administration ('FDA').
(FR)La présente invention concerne des formulations pharmaceutiques et des procédés de délivrance topique et/ou transdermique d'imiquimod, y compris des crèmes, des onguents et des compositions auto-adhésives destinés au traitement de troubles dermatologiques, précisément, d'infections virales, telles que les infections par le virus Herpes simplex Type I ou Type II et les condylomes acuminés, la kératose actinique et les carcinomes basocellulaires superficiels, et à l'induction de la biosynthèse de l'interféron, avec des durées de thérapie plus courtes, que ce qui est actuellement approuvé pour l'imiquimod par la FDA (Food & Drug Administration).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)